Prevention of prostate cancer with oleanane synthetic triterpenoid CDDO-Me in the TRAMP mouse model of prostate cancer

Cancers

Volumn 3, Issue 3, 2011, Pages 3353-3369

  Gao, Xiaohua ^a   Deeb, Dorrah ^a   Liu, Yongbo ^a   Arbab, Ali S ^a   Divine, George W ^a   Dulchavsky, Scott A ^a   Gautam, Subhash C ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Akt mTOR NF kB signaling; Apoptosis; CDDO Me; Chemoprevention; Prostate cancer

Indexed keywords

BARDOXOLONE METHYL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INHIBITION; CANCER PREVENTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISTANT METASTASIS; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; EARLY INTERVENTION; ENZYME INHIBITION; FEMALE; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THERAPY DELAY; TRANSGENIC MOUSE; TREATMENT DURATION;

EID: 80053186327     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3033353     Document Type: Article

References (40)

1. Garnick, M.B. Hormonal therapy in the management of prostate cancer: From Higgins to the present. Urology 1997, 49, 5-15.
2. Hanks, GE. Long-term control of prostate cancer with radiation. Urol. Clin. North Amer. 1996, 23, 605-616.
3. Fleshner, N.E.; Bagnell, P.S.; Klotz, L.H.; Venkateswaran, V. Dietary fat and prostate cancer. J. Urol. 2004, 171, S19-24.
4. Block, G.; Patterson, B.; Subar, A. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr. Cancer 1992, 18, 1-29,
5. Kuo, S.M. Dietary flavonoids and cancer prevention: Evidence and potential mechanism. Crit. Rev. Oncogenesis 1997, 8, 47-69.
6. Gupta, S.; Hastak, K.; Ahmad, N.; Lewin, J.S.; Mukhtar, H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA 2001, 98, 10350-10355.
7. Singh, S.V.; Warin, R.; Xiao, D.; Powolny, A.A.; Stan, S.D.; Arlotti, J.A.; Zeng, Y.; Hahm, E-R.; Marynowski, S.W.; Bommareddy, A.; Desai, D.; Amin, S.; Parise, R.A.; Beumer, J.H.; Chambers, W.H. Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells. Cancer Res. 2010, 69, 2117-2125.
8. Bettuzzi S.; Brausi M.; Rizzi F.; Castagnetti, G.; Peracchia, G.; Corti, A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Res. 2006, 66, 1234-1240.
9. Huang, M.T.; Ho, C.T.; Wang, Z.Y.; Ferraro, T.; Lou, Y.R.; Stauber, K.; Ma, W.; Georgiadis, C.; Laskin, J.D.; Conney, A.H. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res. 1994, 54, 701-707.
10. Nishino, H.; Nishino, A.; Takayasu, J.; Hasegawa, T.; Iwashima, A.; Hirabayashi, K.; wata, S.; Shibata, S. Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13-accetate by some oleanane-type triterpenoid compounds. Cancer Res. 1988, 48, 5210-5215.
11. Ryu, S.Y.; Oak, M.H.; Yoon, S.K.; Cho, D.I.; Yoo, G.S.; Kim, T.S.; Kim, K.M. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med. 2000, 66, 358-360.
12. Honda, T.; Rounds, B.V.; Gribble, G.W.; Suh, N.; Wang, Y.; Sporn, M.B. Design and synthesis of 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages. Biorg. Med. Chem. Lett. 1998, 8, 2711- 2714.
13. Suh, N.; Honda, T.; Finlay, H.J.; Barchowsky, A.; Williams, C.; Benoit, N.E.; Xie, Q.W.; Nathan, C.; Gribble, G.W.; Sporn, M.B. Triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxigenase (COX-2) in mouse macrophages. Cancer Res. 1998, 58, 717-723.
14. Honda, T.; Rounds, B.V.; Bore, L.; Favaloro, F.G.; Gibble, G.W.; Suh, N.; Wang, Y.; Sporn, M.B. Novel synthetic oleanane triterpenoids: A series of highly active inhibitors of nitric oxide production in mouse macrophages. Bioorg. Chem. Lett. 1999, 9, 3429-3434.
15. Gao, X.; Deeb, D.; Jiang, H.; Liu, Y.; Dulchavsky, S.; Gautam S. Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-κB and Notch1 signaling. J. Neurooncol. 2007, 84, 147-157.
16. Deeb, D.; Gao, X.; Dulchavsky, S.A.; Gautam, S.C. CDDO-Me induces apoptosis and inhibits Akt, mTOR and NF-κB in prostate cancer cells. Anticancer Res. 2007, 27, 3035-3044.
17. Konopleva, M.; Tsao, T.; Ruvolo, P.; Stiouf, I.; Estrov, Z.; Leysath, C.E.; Zhao, S.; Harris, D.; Chang, S.; Jackson, C.E.; Munsell, M.; Suh, N.; Gribble, G.; Honda, T.; May, W.S.; Sporn, M.B.; Andreeff, M. Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia. Blood 2002, 99, 326-335.
18. Shishodia, S.; Sethi, G.; Konopleva, M.; Andreeff, M.; Aggarwal, B.B. A synthetic triterpenoid, CDDO-Me, inhibits I kappa B alpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappa B-regulated gene products in human leukemic cells. Clin. Cancer Res. 2006, 12, 1828-1838.
19. Ikeda, T.; Sporn, M.; Honda, T.; Gribble, G.W.; Kufe, D. The novel triterpenoid CDDO and its derivatives induce apoptosis by disruption of intracellular redox balance. Cancer Res. 2003, 63, 5551-5558.
20. Konopleva, M.; Tsao, T.; Estrov, Z.; Lee, R.M.; Wang, R.Y.; Jackson, C.E.; McQueen, T.; Monaco, G.; Munsell, M.; Belmont, J.; Kantarjian, H.; Sporn, M.B.; Andreeff, M. The synthetic triterpenoid 2-cyano-3, 12-dioxooleana-1, 9-dien-28-oic acid induces caspase-dependent and independent apoptosis in acute myelogenous leukemia. Cancer Res. 2004, 64, 7927-7935.
21. Ito, Y.; Pandey, P.; Sporn, M.B.; Datta, R.; Kharbanda, S.; Kufe D. The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism. Mol. Pharmacol. 2001, 59, 1094-1099.
22. Konopleva, M.; Contractor, R.; Kurinna, S.M.; Chen, W.; Andreeff, M.; Ruvolo, P.P. The novel triterpenoid CDDO-Me suppresses MAPK pathways and promotes p38 activation in acute myeloid leukemia cells. Leukemia 2005, 19, 1350-1354.
23. Suh, N.; Roberts, A.B.; Birkey Reffey, S.; Miyazono, K.; Itoh, S.; ten Dijke, P.; Heiss, E.H.; Place, A.E.; Risingsong, R.; Williams, C.R.; Honda, T.; Gribble, G.W.; Sporn, M.B. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling. Cancer Res. 2003, 63, 1371-1376.
24. Chintharlapalli, S.; Papineni, S.; Konopleva, M.; Andreef, M.; Samudio, I.; Safe, S. 2-Cyano- 3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways. Mol. Pharmacol. 2005, 68, 119-128.
25. Yates, M.S.; Kwak, M.K.; Egner, P.A.; Groopman, J.D.; Bodreddigari, S.; Sutter, T.R.; Baumgartner, K.J.; Roebuck, B.D.; Liby, K.T.; Yore, M.M.; Honda, T.; Gribble, G.W.; Sporn, M.B.; Kensler, T.W. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. Cancer Res. 2006, 66, 2488-2494.
26. Xiaoyang, L.; Konopleva, M.; Zeng, Z.; Ruvolo, V.; Stephens, L.C.; Schober, W.; McQueen, T.; Dietrich, M.; Madden, T.L.; Andreeff, M. The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling. Cancer Res. 2007, 67, 4210-4218.
27. Liby, K.; Royce, D.B.; Williams, C.R.; Risingsong, R.; Yore, M.M.; Honda, T.; Gribble, G.W.; Dmitrovsky, E.; Sporn, T.A.; Sporan MB. The synthetic triterpenoid CDDO-methyl ester and CDDO-amide prevent lung cancer induced by vinyl carbomate in A/J mice. Cancer Res. 2007, 67, 2414-2419.
28. Deeb, D.; Gao, X.; Jiang, H.; Dulchavsky, S.A.; Gautam, S.C. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR. Prostate 2009, 69, 851-860.
29. Deeb, D.; Gao, X.; Liu, Bo.; Jiang, D.; Divine, G.; Arbab, S.A.; Dulchavsky, S.A.; Gautam, S.C. Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling. Carcinogenesis 2011, doi:10.1093/carcin/bgr030.
30. Deeb, D.; Gao, X.; Dulchavsky, S.A.; Gautam, S.C. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-κB and NF-κB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells. J. Exp. Therapeut. Oncol. 2008, 7, 31-39.
31. Gao, X.; Deeb, D.; Jiang, H.; Liu, Y.; Arbab, Ali S. Dulchavsky, S.; Gautam S.C. Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-κB signaling proteins in colorectal cancer cells. Anticancer Res. 2010, 30, 785-792.
32. Singh, S.V.; Powolny, A.A.; Stan, S.D.; Xiao, D.; Arlotti, J.A.; Warin, R.; Hahm, E-R.; Marynowki, S.W.; Bommareddy, A.; Potter, D.M.; Dhir, R. Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice. Cancer Res. 2008, 68, 9503-9511.
33. Mentor-Marcel, R.; Lamartiniere, C.A.; Eltoum, I.E.; Greenberg, N.M.; Elgavish, A. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res. 2001, 61, 6777-6782.
34. Datta, S.R.; Dudek, H.; Tao, X.; Masters, S.; Fu, H.; Gotoh, Y.; Greenberg, M.E. Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91, 231-241.
35. Brunet, A.; Bonni, A.; Zigmond, M.J.; Lin, M.Z.; Juo, P.; Hu, L.S.; Anderson, M.J.; Arden, K.C.; Blenis, J.; Greenberg, M.E. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 1999, 96, 857-868.
36. Mayo, M.W.; Baldwin A.S. The transcription factor NF-_B: control of oncogenesis and cancer therapy resistance. Biochim. Biophys. Acta. 2000, 1470, M55-M62.
37. Hay, N.; Sonenberg, N. Upstream and downstream of mTOR. Gene Dev. 2006, 18, 1926-1945.
38. Shukla, S.; MacLennan, G.T.; Marengo, S.R.; Resnick, M.I.; Gupta, S. Constitutive activation of PI3K-Akt and NF-kB during prostate cancer progression in autochthonous transgenic mouse model. Prostate 2005, 64, 224-239.
39. Kaplan-Lefco, P.J.; Chen, T-M.; Ittman, M.M.; Barrios, R.J.; Ayala, G.E.; Huss, W.J.; Maddison, L.A.; Foster, B.A.; Greenberg, N.M. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 2003, 55, 219-237.
40. Gingrich, J.R.; Barrios, R.J.; Foster, B.A.; Greenberg, N.M. Pathologic progression of autochthonous prostate cancer in TRAMP model. Prostate Cancer Prostatic Dis. 1999, 2, 70-75.